Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.
about
Engineering galectin-glycan interactions for immunotherapy and immunomodulationRational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignancies.Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.Role of MSC-derived galectin 3 in the AML microenvironment.Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.
P2860
Q37107168-1B7257DB-8A79-4C95-B3B6-EA984B11C572Q38637652-AF80ACCB-69EB-4FBD-A69C-96BD886EA563Q38722012-D50DDE80-4B07-4F33-A56C-5177E64AB93EQ47333014-DD3508B3-900B-4909-B157-E8C29982A24EQ48270428-CEACA6EB-5517-419C-B3B1-598567AB4F00Q52588202-547AE333-F751-4DDD-BDBD-FBA9EF8E2E74Q52724033-7704CFD7-D614-4FEC-933B-243524D0AF38Q52777531-0AEB1966-91BA-4D0C-843D-3B91562920F4
P2860
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Combination of galectin inhibi ...... d type and p53 null AML cells.
@ast
Combination of galectin inhibi ...... d type and p53 null AML cells.
@en
type
label
Combination of galectin inhibi ...... d type and p53 null AML cells.
@ast
Combination of galectin inhibi ...... d type and p53 null AML cells.
@en
prefLabel
Combination of galectin inhibi ...... d type and p53 null AML cells.
@ast
Combination of galectin inhibi ...... d type and p53 null AML cells.
@en
P2093
P2860
P1476
Combination of galectin inhibi ...... d type and p53 null AML cells.
@en
P2093
Ahmed AlRawi
Christopher B Benton
George Tidmarsh
James Rolke
Jared K Burks
Peter P Ruvolo
R Eric Davis
Vivian R Ruvolo
Wendy Schober
P2860
P304
P356
10.1016/J.BBAMCR.2015.12.008
P407
P577
2015-12-15T00:00:00Z